citation_journal,link,PMID
"Michielsen K, Dresen R, Vanslembrouck R, Keyzer F, Amant F, Mussen E, et al. Diagnostic value of whole body diffusion‐weighted MRI compared to computed tomography for pre‐operative assessment of patients suspected for ovarian cancer.  European Journal of Cancer 2017;83:88‐98. [PUBMED: 28734146] CENTRAL   Google Scholar",https://www.ncbi.nlm.nih.gov/pubmed/28734146,28734146.0
"Forstner R, Hricak H, Occhipinti KA, Powell CB, Frankel SD, Stern JL. Ovarian cancer: staging with CT and MR imaging.  Radiology 1995;197:619‐26.  CENTRAL   Google Scholar",https://www.ncbi.nlm.nih.gov/pubmed/7480729,7480729.0
"Alessi A, Martinelli F, Padovano B, Serafini G, Lorusso D, Lorenzoni A, et al. FDG‐PET/CT to predict optimal primary cytoreductive surgery in patients with advanced ovarian cancer: preliminary results.  Tumori 2016;102:103‐7. [DOI: 10.5301/tj.5000396] CENTRAL   Google Scholar",https://www.ncbi.nlm.nih.gov/pubmed/26350201,26350201.0
"Espada M, Garcia‐Flores JR, Jimenez M, Alvarez‐Moreno E, Haro M, Gonzalez‐Cortijo L, et al. Diffusion‐weighted magnetic resonance imaging evaluation of intra‐abdominal sites of implants to predict likelihood of suboptimal cytoreductive surgery in patients with ovarian carcinoma.  European Radiology 2013;23:2636‐42. [DOI: 10.1007/s00330‐013‐2837‐7] CENTRAL   Google Scholar",https://www.ncbi.nlm.nih.gov/pubmed/23604800,23604800.0
"Shim SH, Lee SJ, Kim SO, Kim SN, Kim DY, Lee JJ, et al. Nomogram for predicting incomplete cytoreduction in advanced ovarian cancer patients.  Gynecologic Oncology 2015;136:30‐6.  CENTRAL   Google Scholar",https://www.ncbi.nlm.nih.gov/pubmed/25448457,25448457.0
